Immunotherapy
What is Immunotherapy?
Immunotherapy are latest medicines in the field of cancer care that has revolutionized the treatment of many tumours particularly in Stage 4 cancers.
How does immunotherapy act?
Usually . the body uses its immune system to fight the cancer cells and keep it under control and prevent it from expanding. However during the course, these cells cleverly try to evade and escape the immune system by interacting with certain proteins called CHECKPOINTS which prevent the immune system from attacking the cancer cells .
Immunotherapy commonly makes use of drugs called CHECKPOINT INHIBITORS such as Pembrolizumab, Nivolumab, Atezolizumab and Durvalumab which target the PD-1/PDL-1 axis and unblocks the immune system to fight cancer
In which cancers can immunotherapy be used?
Immunotherapy is most often used in Stage 4 cancers. Some of the cancers in which it has been approved are
- Lung cancer
- Cancers of the Oral cavity ( Head and neck malignancies)
- Kidney cancer
- Melanoma
- Stomach/Esophageal cancers
- Gall bladder/Biliary Cancer
- Colon/uterine cancers with deficiency of mismatch repair proteins
How beneficial is Immunotherapy?
Immunotherapy has produced dramatic responses. While it may not work in all patients, in those who respond, we see prolonged survival stretching in years even in Stage 4 cancers.
Immunotherapy has the potential to produce dramatic responses and even in stage 4 cancer, make the disease disappear completely on imaging (known as Complete response) in a small proportion of patients who take it
Here is a case of a patient with stage 4 kidney cancer which had spread to the bones, liver and lung having no remarkable reduction of the disease on PET scan after just 2 months of treatment with immunotherapy
Are there any special tests to be done before immunotherapy is started to predict response?
In certain tumours , we test the biopsy sample for a marker known as PDL-1 and strong positivity is associated with better response to immunotherapy.
Apart from this in certain stage 4 tumours of the intestine (Colon cancer) or Uterine cancer, we also test the biopsy sample for deficiency in certain proteins known as Mismatch repair proteins( MMR) which again indicate better response to immunotherapy.
In tumours such as stage 4 kidney cancer, immunotherapy is used irrespective of any markers and testing is not required
Are there any side effects of immunotherapy?
Immunotherapy is usually well tolerated and not associated with side effects typically seen with chemotherapy. Immunotherapy is used even in the very elderly patients above the age of 80 years.
The side effects of immunotherapy observed are mostly autoimmune in nature where the body’s immune system may get overactivated. The most common side effects seen with immunotherapy are fluctuations of the thyroid levels, and skin rash.
Some patients may experience diarrhea or joint pains and rarely inflammation of the lungs known as pneumonitis.
